medline.ch Respirationstrakt Neoplasie

	Multimodal AI for pneumonia and lung cancer classification using x-ray and HRCT. Bioinformation Pradip C, Girish C, Bhoomika C, Jayesh V, Lalit R, Simmi M. PMID: 41960513 [PubMed - in process]
	Combined single-cell transcriptome and Mendelian randomization to identify and validate prognostic genes associated with endoplasmic reticulum stress and butyrate metabolism in lung adenocarcinoma. Front Genet Li J, Shen F, Zha J, Zhou M, Yi N, Li K, Li Y. PMID: 41960145 [PubMed - in process]
	Neoadjuvant intratumoral immune stimulation using gene-mediated cytotoxic immunotherapy for resectable non-small cell lung cancer: 5-Year outcomes. JTCVS Open Aicher A, Rekhtman D, Eisinger E, Niemeyer E, Davis C, Haas A, Nichols WG, Aguilar L, Aguilar-Cordova E, Kucharczuk J, Pechet T, Jarrar D, Singhal S, Albelda S, Predina J. PMID: 41960082 [PubMed - in process]
	What should lung cancer patients know before surgery? A Delphi consensus study. JTCVS Open Jang W, Ferguson MK, Antonoff M, Block M, DeCamp M Jr, Dexter E, Donington J, Edwards M, Erickson C, Greenfield DT, Grogan EL, Hagen J, Inra ML, Kaban J, Kneuertz PJ, Kwon S, Lam G, Mortman K, Naunheim K, Pettiford B, Raymond DP, Reisenauer JS, Ripley RT, Robinson L, Seder CW, Soukiasian H, Thanawala R, Valsangkar N, Veeramachaneni N, Wallen J, Watson T, Wiesel O, Madariaga MLL. PMID: 41960080 [PubMed - in process]
	Diagnostic Utility of Immunohistochemistry in Lung Carcinoma Subtyping: A Clinicopathological Study From a Tertiary Care Center. Cureus Mantri A, Pathak D, Samanta M, Haripura JA, Nikhra P. PMID: 41959987 [PubMed - in process]
	A meta-analysis of the impact of different ALK variants on targeted therapy efficacy in advanced non-small cell lung cancer. Front Oncol Gu Z, Chen Z, Lai Q, Lin D. PMID: 41959926 [PubMed - in process]
	Evolving treatment strategies for HER2-altered non-small-cell lung cancer: the rise of TKIs and ADCs. Front Oncol Balli S, Basoglu T, Ozdogan M. PMID: 41959903 [PubMed - in process]
	Defining mutational signatures of lung cancer-associated carcinogens through in vitro exposure of human airway epithelial cells. bioRxiv Gurevich NQ, Chiu DJ, Yajima M, Huggins J, Mazzilli SA, Campbell JD. PMID: 41959104 [PubMed]
	Concurrent moxifloxacin-induced liver injury and toxic epidermal necrolysis after immune checkpoint inhibition: a case report and literature review. Front Immunol Li Q, Wang L, Xu H, Huang T, Hong H, Ji X, Liu J. PMID: 41958644 [PubMed - indexed for MEDLINE]
	Defining the tumor microenvironment of non-small cell lung cancer. Immunol Cell Biol Embaye KS, Blick T, Naei VY, O'Byrne K, Hughes BGM, Kulasinghe A. PMID: 41958218 [PubMed - as supplied by publisher]
	Early Clinical Experience With the Hinotori Robotic Surgical System: Comparable Perioperative Outcomes With the da Vinci Platform in Primary Lung Cancer. Asian J Endosc Surg Kubouchi Y, Yasuda R, Nozaka Y, Fujiwara W, Matsui S, Tanaka Y. PMID: 41958206 [PubMed - indexed for MEDLINE]
	Effect of Interval Between Neoadjuvant Immunochemotherapy and Radical Resection of Non-Small Cell Lung Cancer: A Multicenter, Retrospective Cohort Study. Int J Cancer Wang J, Song P, Ge Y, Yang H, Li S, Ma R, Ma T, Feng S, Zhang C, Sun T, Yao F, Yi J, Zhang H. PMID: 41957998 [PubMed - as supplied by publisher]
	Nanomedicine novel strategies: deciphering the EV-metabolic axis as a natural nanocarrier network in lung cancer progression and cachexia. J Nanobiotechnology Zhao X, Lv D, Wang M, Guo Q, Gao Y, Fang W, Zhang W, Wu P. PMID: 41957861 [PubMed - as supplied by publisher]
	Clinical Outcomes of the POPCORN Study: Pharmacodynamics of Pre-Operative PD1 CheckpOint Blockade and Receptor Activator of NF-ÎºB Ligand (RANKL) Inhibition in Non-Small Cell Lung Cancer (NSCLC)-A Phase 1B/2 Trial. Asia Pac J Clin Oncol Ahern E, Turner C, Naidoo R, Godbolt D, Ives A, Popplewell K, Lwin Z, Pearson S, Nelson K, Madore J, Dougall WC, Hughes BGM. PMID: 41957527 [PubMed - as supplied by publisher]
	Explainable deep learning-based lung cancer diagnosis using clinically-guided local interpretable model-agnostic explanations. Sci Rep Hassan SU, Abdulkadir SJ, Alhussian HS, Fayyaz AM, Al-Selwi SM, Khan U, Ismail AOA. PMID: 41957146 [PubMed - as supplied by publisher]
	Impact of tumor location on the efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer. Br J Cancer Ozawa Y, Yamamoto K, Sugawara S, Niho S, Okamoto H, Hotta K, Okamoto I, Ikeda N, Yamamoto N. PMID: 41957135 [PubMed - as supplied by publisher]
	The Optimization of Radiotherapy in Lung Cancer Treatment: 20 Years of Progress. J Thorac Oncol Salama JK, Mix MD, Faivre-Finn C, Bezjak A, Bogart JA. PMID: 41956630 [PubMed - indexed for MEDLINE]
	Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw Riely GJ, Wood DE, Aisner DL, Axtell AL, Bauman JR, Bharat A, Chang JY, Desai A, Dilling TJ, Dowell J, Durm GA, Gettinger S, Grotz TE, Gubens MA, Juloori A, Lackner RP, Lanuti M, Levy B, Lin J, Loo BW Jr, Lovly CM, Maldonado F, Morgensztern D, Mullikin TC, Ng T, Owen D, Owen DH, Patil T, Polanco PM, Riess J, Mendez ALR, Shapiro TA, Singh AP, Stevenson J, Tam A, Tanvetyanon T, Yanagawa J, Yau E, Yun K, Gregory K, Hang L. PMID: 41956107 [PubMed - indexed for MEDLINE]
	Comparison of the effects of different types of treatment protocols on the median and overall survival rates of non-small cell lung cancer patients: A real-world retrospective study. PLoS One Siahmansur TJ. PMID: 41955266 [PubMed - indexed for MEDLINE]
	Association of medicaid expansion with lung cancer-specific and overall mortality: A difference-in-differences analysis. PLoS One Akinyemi O, Fasokun M, Eze A, Ugochukwu N, Arshad S, Belie O, Hughes K, Cornwell Iii E, Levy G. PMID: 41955246 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 158731

Seite 1 von 7937



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung